Lack of comparability of immunoassays for rheumatoid factor isotypes
© 2023 Walter de Gruyter GmbH, Berlin/Boston..
OBJECTIVES: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterised by the presence of autoantibodies that are used for classification of the disease. Though routine diagnostics is commonly restricted to measuring rheumatoid factor (RF) and anti-citrullinated protein antibodies, detection of RF IgM, IgG and IgA isotypes, may increase the power of RA serodiagnosis by reducing the number of seronegative patients as well as provide prognostic information. The agglutination-based RF assays, such as nephelometry or turbidimetry, are unable to differentiate isotypes. We compared three different immunoassays used in current laboratory practice to detect RF isotypes.
METHODS: We tested 117 consecutive serum samples that were positive for total RF at nephelometry, from 55 RA and 62 non-RA subjects. IgA, IgG, and IgM isotypes of RF were tested by immunoenzymatic (ELISA, Technogenetics), fluoroenzymatic (FEIA, ThermoFisher) and chemiluminescence (CLIA, YHLO Biotech Co.) immunoassays.
RESULTS: Diagnostic performance differed considerably between the assays, especially with regard to RF IgG isotype. Agreement among methods by Cohen's kappa ranged from 0.05 (RF IgG CLIA vs. FEIA) to 0.846 (RF IgM CLIA vs. FEIA).
CONCLUSIONS: The poor agreement observed in this study indicates substantial lack of comparability among assays for RF isotypes. Harmonization of these tests requires further efforts before their measurement can be used in clinical practice.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:61 |
---|---|
Enthalten in: |
Clinical chemistry and laboratory medicine - 61(2023), 9 vom: 28. Aug., Seite 1619-1622 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Infantino, Maria [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 17.07.2023 Date Revised 24.01.2024 published: Electronic-Print Citation Status MEDLINE |
---|
doi: |
10.1515/cclm-2023-0109 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM355325500 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM355325500 | ||
003 | DE-627 | ||
005 | 20240125231835.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1515/cclm-2023-0109 |2 doi | |
028 | 5 | 2 | |a pubmed24n1270.xml |
035 | |a (DE-627)NLM355325500 | ||
035 | |a (NLM)37027892 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Infantino, Maria |e verfasserin |4 aut | |
245 | 1 | 0 | |a Lack of comparability of immunoassays for rheumatoid factor isotypes |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.07.2023 | ||
500 | |a Date Revised 24.01.2024 | ||
500 | |a published: Electronic-Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 Walter de Gruyter GmbH, Berlin/Boston. | ||
520 | |a OBJECTIVES: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterised by the presence of autoantibodies that are used for classification of the disease. Though routine diagnostics is commonly restricted to measuring rheumatoid factor (RF) and anti-citrullinated protein antibodies, detection of RF IgM, IgG and IgA isotypes, may increase the power of RA serodiagnosis by reducing the number of seronegative patients as well as provide prognostic information. The agglutination-based RF assays, such as nephelometry or turbidimetry, are unable to differentiate isotypes. We compared three different immunoassays used in current laboratory practice to detect RF isotypes | ||
520 | |a METHODS: We tested 117 consecutive serum samples that were positive for total RF at nephelometry, from 55 RA and 62 non-RA subjects. IgA, IgG, and IgM isotypes of RF were tested by immunoenzymatic (ELISA, Technogenetics), fluoroenzymatic (FEIA, ThermoFisher) and chemiluminescence (CLIA, YHLO Biotech Co.) immunoassays | ||
520 | |a RESULTS: Diagnostic performance differed considerably between the assays, especially with regard to RF IgG isotype. Agreement among methods by Cohen's kappa ranged from 0.05 (RF IgG CLIA vs. FEIA) to 0.846 (RF IgM CLIA vs. FEIA) | ||
520 | |a CONCLUSIONS: The poor agreement observed in this study indicates substantial lack of comparability among assays for RF isotypes. Harmonization of these tests requires further efforts before their measurement can be used in clinical practice | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a agreement | |
650 | 4 | |a isotypes | |
650 | 4 | |a nephelometry | |
650 | 4 | |a rheumatoid arthritis | |
650 | 4 | |a rheumatoid factor | |
650 | 7 | |a Rheumatoid Factor |2 NLM | |
650 | 7 | |a 9009-79-4 |2 NLM | |
650 | 7 | |a Immunoglobulin Isotypes |2 NLM | |
650 | 7 | |a Autoantibodies |2 NLM | |
650 | 7 | |a Immunoglobulin G |2 NLM | |
650 | 7 | |a Immunoglobulin M |2 NLM | |
650 | 7 | |a Immunoglobulin A |2 NLM | |
700 | 1 | |a Palterer, Boaz |e verfasserin |4 aut | |
700 | 1 | |a Pancani, Silvia |e verfasserin |4 aut | |
700 | 1 | |a Benucci, Maurizio |e verfasserin |4 aut | |
700 | 1 | |a Grossi, Valentina |e verfasserin |4 aut | |
700 | 1 | |a Manfredi, Mariangela |e verfasserin |4 aut | |
700 | 1 | |a Bizzaro, Nicola |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical chemistry and laboratory medicine |d 1998 |g 61(2023), 9 vom: 28. Aug., Seite 1619-1622 |w (DE-627)NLM095304118 |x 1437-4331 |7 nnns |
773 | 1 | 8 | |g volume:61 |g year:2023 |g number:9 |g day:28 |g month:08 |g pages:1619-1622 |
856 | 4 | 0 | |u http://dx.doi.org/10.1515/cclm-2023-0109 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 61 |j 2023 |e 9 |b 28 |c 08 |h 1619-1622 |